FDA Investigator Chad E Schmear

Chad E Schmear has conducted inspections on 121 sites in 6 countries as of 15 May 2003. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
121
Last Inspection Date:
15 May 2003
Investigator Role:
FDA Investigator
Redica ID:
100000667
Countries of Inspections:
United States of America, Dominican Republic, Costa Rica, United Kingdom of Great Britain and Northern Ireland, Mexico, Ireland
FDA Investigators that have inspected at least one site in common with Chad E Schmear:
Alicia M Mozzachio, Althea A Williams, Amanda Dinaro, Amanda S Zorn, Ana L Kewes, Anders W Evenson, Andrew A Leboeuf, Anna Flynn, Anthony F Lorenzo, Anthony R Ronga, Antoinette L Chancey, Audrey Dela Cruz, Bradley J Maunder, Brian D Nicholson, Bruce H Mccullough, Burnell M Henry, Carl A Huffman, III, Carlyn L Ray, Carrie Ann Plucinski, CDR Sean T Creighton, Charles R Cote, RIC, Chase S Baldwin, Cheryl D Mccall, Chiang Syin, PhD, Christine E Kelley, Christopher B Harding, Christopher D Leach, Clotia Cabbey Mensah, Corey K Reno, Creighton T Tuzon, Daniel C Kearns, Daniel Kearns, Daniel L Aisen, Darrell E Luedtke, David J Gasparovich, David Perkins, Dawn M Braswell, Debra I Love, Debra Lboyd Seale, Denarvis C Mendenhall, Denise L Burosh, Devaughn Edwards, Diane Kretschmer, Dianiris C Ayala, Dolores Harper, Dr. Gang Wang, PhD, Dr. Guang Gao, PhD, Edward J Janik, Elizabeth L Holmes, Elliot P Cowam, PhD, Emma R Schaefer, Eric M Mueller, PharmD, Eric S Pittman, Gene D Arcy, Gregory R Dill, Helen B Ricalde, Humera T Khan, Jacqueline Mdiaz Albertini, James A Beaulieu, James P Duggan, James W Plucinski, Jan B Welch, Janis R Armedoriz, Jason F Chancey, Jeanne J Chiu, Jeanne M Morris, Jeffry A Bernhardt, Jennifer C Adams, Jennifer C Johnson, Jesse A Vazquez, Joan A Loreng, Joel D Hustedt, John A Iwen, John M Seale, John P Hermann, Joseph A Morkunas, Joseph A Piechocki, Joseph D Cooper, Joshua M Adams, Juanita Banuelos, Julie D Bringger, Justin A Boyd, Justine Tomasso, Karen Emasley Joseph, Kathleen A Schelble, Kathleen B Swat, Kathleen S Tormey, Kim M Wiegand, Kimberly Lewandowski Walker, Kimberly W Destromp, Kirtida Patel, Kujtim Sadiku, Kyran R Gibson, Laiza V Garcia, Lakisha M Williams, Larry F Hallberg, Laureen M Geniusz, Laurie A Haxel, Lee Terry Moore, Lequita M Mayhew, Lisa Hayka, Lisa Hornback, Lisa M Lopez, Lorelei S Jarrell, Maksim A Levenchuk, Margaret Torres Vazquez, Maria Diaz, Maribeth G Niesen, Marie A Fadden, Mark E Frank, Mark G Peterson, Mark I Kaspar, Martha T Olone, Matthew J Sienko, Matthew R Buenconsejo, Maureen C Melvin, Melanie W Pishnery, Michael D Robinson, Michele L Glendenning, Michelle J Glembin, Natasha R Johnson, Nibin Varghese, MS, Nicholas F Lyons, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Norman L Brown, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick E Gainer, Paul L Bellamy, Phung Thien Nguyen, Prabhu P Raju, Rachel T Evans, Rafael Padilla, Ralph Jerndal, Raul Alicea, Richard K Vogel, Robert L Stevenson, Roberta W Cunningham, Rose Ashley, Rosemary Wood Sexton, Roy Baby, Russell K Riley, Ryan Gibson, Sandra A Hughes, Sarah B Tanksley, Selene T Torres, Shafiq S Ahadi, Shana L Williams, Sherea L Dillon, Simone E Pitts, Sonya L Karsik, RAC, Stefen D Mcmillan, Stephen D Eich, Steven J Lynn, Sullan, Susan A Zullo, PhD, Susan M Jackson, Susan P Bruederle, Susan W Ciani, Tamara Brey, Tara M Aikens, Tara M Humfeld, That Q Dang, Thunder N Dunkijacobs, Thunder N Senita, Todd M Stankewicz, Todd Q Dang, William D Sherman, William R Weissinger, Yvonne E Lozano, Zerita White

Chad E Schmear's Documents

Publish Date Document Type Title
October, 2002 EIR Abbott Laboratories - EIR, 2002-10-03
January, 2003 FDA 483 Medsorb Dominicana, S.A. - Form 483, 2003-01-29
April, 2000 EIR Abbott Laboratories - EIR, 2000-04-10
April, 2000 FDA 483 Abbott Laboratories - Form 483, 2000-03-31
September, 2002 EIR Baxter Healthcare Renal Div - EIR, 2002-09-20
March, 2003 FDA 483 Baxter Healthcare Corporation - Form 483, 2003-03-03
January, 2003 EIR Medsorb Dominicana, S.A. - EIR, 2003-01-29
December, 2000 EIR GE Healthcare Inc. - EIR, 2000-12-15
October, 2002 FDA 483 Response Abbott Laboratories - Form 483R, 2002-10-24
March, 2003 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2003-04-07
March, 2003 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2003-03-20
September, 2002 FDA 483 Response Baxter Healthcare Renal Div - Form 483R, 2002-09-27
February, 2002 EIR Sterigenics U.S., LLC - EIR, 2002-02-26
May, 2000 EIR Baxter Healthcare Corporation - EIR, 2000-05-05
March, 2003 FDA 483 Baxter Healthcare Corporation - Form 483, 2003-03-24
March, 2000 FDA 483 MRL, Inc., A Welch Allyn Company - Form 483, 2000-03-08
March, 2003 EIR Baxter Healthcare Corporation - EIR, 2003-03-24
February, 2003 EIR Baxter Productos Medicos, Ltda. - EIR, 2003-02-06
March, 2002 FDA 483 EES S.A. de CU (Ethicon Endo-Surgery) - Form 483, 2002-03-21
August, 2002 EIR Baxter Healthcare Corporation - EIR, 2002-08-13
August, 2002 FDA 483 H & P Industries, Inc. - Form 483, 2002-08-29
March, 2003 EIR Baxter Healthcare Corporation - EIR, 2003-03-03
March, 2002 EIR EES S.A. de CU (Ethicon Endo-Surgery) - EIR, 2002-03-21
September, 2002 FDA 483 Baxter Healthcare Renal Div - Form 483, 2002-09-20
November, 2000 EIR Baxter Healthcare Corporation - EIR, 2000-11-15
April, 2000 FDA 483 Response Abbott Laboratories - Form 483R, 2000-08-28
April, 2000 FDA 483 Response Abbott Laboratories - Form 483R, 2000-04-13
April, 2000 EIR Abbott Laboratories - EIR, 2000-03-31
February, 2002 EIR Sysmex America, Inc. - EIR, 2002-02-15
November, 2000 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2000-11-28
June, 2000 EIR American Health Service Sales - EIR, 2000-06-21
October, 2001 FDA 483 Medco Instruments Inc - Form 483, 2001-10-19
November, 2000 FDA 483 Baxter Healthcare Corporation - Form 483, 2000-11-15
March, 2000 EIR MRL, Inc., A Welch Allyn Company - EIR, 2000-03-08
June, 2000 EIR Baxter Healthcare Corporation - EIR, 2000-06-29
August, 2002 FDA 483 Baxter Healthcare Corporation - Form 483, 2002-08-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more